TY - JOUR
T1 - Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alveolar macrophages upon pulmonary β-glucan-induced inflammatory adaptation
AU - Theobald, H.
AU - Bejarano, D. A.
AU - Katzmarski, N.
AU - Haub, J.
AU - Schulte-Schrepping, J.
AU - Yu, J.
AU - Bassler, K.
AU - Ament, A. L.
AU - Osei-Sarpong, C.
AU - Piattini, F.
AU - Vornholz, L.
AU - T’Jonck, W.
AU - Györfi, A. H.
AU - Hayer, H.
AU - Yu, X.
AU - Sheoran, S.
AU - Al Jawazneh, A.
AU - Chakarov, S.
AU - Haendler, K.
AU - Brown, G. D.
AU - Williams, D. L.
AU - Bosurgi, L.
AU - Distler, J. H.W.
AU - Ginhoux, F.
AU - Ruland, J.
AU - Beyer, M. D.
AU - Greter, M.
AU - Bain, C. C.
AU - Vazquez-Armendariz, A. I.
AU - Kopf, M.
AU - Schultze, J. L.
AU - Schlitzer, A.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/6/1
Y1 - 2024/6/1
N2 - The lung is constantly exposed to the outside world and optimal adaptation of immune responses is crucial for efficient pathogen clearance. However, mechanisms that lead to lung-associated macrophages’ functional and developmental adaptation remain elusive. To reveal such mechanisms, we developed a reductionist model of environmental intranasal β-glucan exposure, allowing for the detailed interrogation of molecular mechanisms of pulmonary macrophage adaptation. Employing single-cell transcriptomics, high-dimensional imaging and flow cytometric characterization paired with in vivo and ex vivo challenge models, we reveal that pulmonary low-grade inflammation results in the development of apolipoprotein E (ApoE)-dependent monocyte-derived alveolar macrophages (ApoE+CD11b+ AMs). ApoE+CD11b+ AMs expressed high levels of CD11b, ApoE, Gpnmb and Ccl6, were glycolytic, highly phagocytic and produced large amounts of interleukin-6 upon restimulation. Functional differences were cell intrinsic, and myeloid cell-specific ApoE ablation inhibited Ly6c+ monocyte to ApoE+CD11b+ AM differentiation dependent on macrophage colony-stimulating factor secretion, promoting ApoE+CD11b+ AM cell death and thus impeding ApoE+CD11b+ AM maintenance. In vivo, β-glucan-elicited ApoE+CD11b+ AMs limited the bacterial burden of Legionella pneumophilia after infection and improved the disease outcome in vivo and ex vivo in a murine lung fibrosis model. Collectively these data identify ApoE+CD11b+ AMs generated upon environmental cues, under the control of ApoE signaling, as an essential determinant for lung adaptation enhancing tissue resilience.
AB - The lung is constantly exposed to the outside world and optimal adaptation of immune responses is crucial for efficient pathogen clearance. However, mechanisms that lead to lung-associated macrophages’ functional and developmental adaptation remain elusive. To reveal such mechanisms, we developed a reductionist model of environmental intranasal β-glucan exposure, allowing for the detailed interrogation of molecular mechanisms of pulmonary macrophage adaptation. Employing single-cell transcriptomics, high-dimensional imaging and flow cytometric characterization paired with in vivo and ex vivo challenge models, we reveal that pulmonary low-grade inflammation results in the development of apolipoprotein E (ApoE)-dependent monocyte-derived alveolar macrophages (ApoE+CD11b+ AMs). ApoE+CD11b+ AMs expressed high levels of CD11b, ApoE, Gpnmb and Ccl6, were glycolytic, highly phagocytic and produced large amounts of interleukin-6 upon restimulation. Functional differences were cell intrinsic, and myeloid cell-specific ApoE ablation inhibited Ly6c+ monocyte to ApoE+CD11b+ AM differentiation dependent on macrophage colony-stimulating factor secretion, promoting ApoE+CD11b+ AM cell death and thus impeding ApoE+CD11b+ AM maintenance. In vivo, β-glucan-elicited ApoE+CD11b+ AMs limited the bacterial burden of Legionella pneumophilia after infection and improved the disease outcome in vivo and ex vivo in a murine lung fibrosis model. Collectively these data identify ApoE+CD11b+ AMs generated upon environmental cues, under the control of ApoE signaling, as an essential determinant for lung adaptation enhancing tissue resilience.
UR - http://www.scopus.com/inward/record.url?scp=85191404305&partnerID=8YFLogxK
U2 - 10.1038/s41590-024-01830-z
DO - 10.1038/s41590-024-01830-z
M3 - Article
AN - SCOPUS:85191404305
SN - 1529-2908
VL - 25
SP - 994
EP - 1006
JO - Nature Immunology
JF - Nature Immunology
IS - 6
ER -